EUVIMEDEUVIMED entdecken
Crossref

Multiparametric 18F-FDG PET/MRI based on restrictive spectrum imaging and amide proton transfer-weighted imaging facilitates the assessment of lymph node metastases in non-small cell lung cancer

Nan Meng, Xue Liu, Yihang Zhou, Xuan Yu, Yaping Wu, Fangfang Fu, Jianmin Yuan, Yang Yang, Zhe Wang, Meiyun Wang

La radiologia medica · 2025

DOI: 10.1007/s11547-025-01992-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift La radiologia medica, 2025. Verfasst von Nan Meng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Henan Provincial People's Hospital and Zhengzhou University People's Hospital, Zhengzhou, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Lymphatic Metastasis, Positron-Emission Tomography. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: The National Key R&D Program of China, the National Natural Science Foundation of China, the Zhongyuan Thousand Talents Plan Project - Basic Research Leader Talent.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: To investigate the value of multiparametric 18F-FDG PET/MRI based on tri-compartmental restrictive spectrum imaging (RSI), amide proton transfer-weighted imaging (APTWI), and diffusion-weighted imaging (DWI) in the assessment of lymph node metastasis (LNM) of non-small cell lung cancer (NSCLC). METHODS: A total of 152 patients (LNM-positive, 86 cases; LNM-negative, 66 cases) with NSCLC underwent chest multiparametric 18F-FDG PET/MRI were enrolled. 18F-FDG PET- derived parameter (SUVmax), RSI-derived parameters (f1, f2, and f3), APTWI-derived parameter (MTRasym(3.5 ppm)), DWI-derived parameter (ADC), and were calculated and compared. Logistic regression analysis was used to identify independent predictors, and combined diagnostics. Area under the receiver operating characteristic curve (AUC), calibration curves and decision curve analysis (DCA) were employed to assess the performance of the combined diagnostics. RESULTS: MTRasym(3.5 ppm), SUVmax, f2, and f3 were higher and ADC and f1 were lower in LNM-positive group than in LNM-negative group (all P < 0.05). Maximum lesion diameter, f1, MTRasym(3.5 ppm), SUVmax, and ADC were independent predictors of LNM status in NSCLC patients, and the combination of them had an optimal diagnostic efficacy (AUC = 0.978; sensitivity = 95.35%; specificity = 90.91%), which was significantly higher than maximum lesion diameter, f1, MTRasym(3.5 ppm), SUVmax, and ADC (AUC = 0.774, 0.810, 0.832, 0.834, and 0.783, respectively, and all P < 0.01). The combined diagnosis showed a good performance (AUC = 0.968) in the bootstrap (1000 samples)-based internal validation. Calibration curves and DCA demonstrated that the combined diagnosis not only provided better stability, but also resulted in a higher net benefit for the patients involved. CONCLUSION: Multiparametric 18F-FDG PET/MRI based on RSI, APTWI, and DWI is beneficial for the non-invasive assessment of LNM status in NSCLC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsLymphatic MetastasisPositron-Emission TomographyMultiparametric Magnetic Resonance ImagingHumansFemaleMaleFluorodeoxyglucose F18Middle AgedRadiopharmaceuticalsAgedRetrospective StudiesMultimodal ImagingAdult

Stichwörter der Autor:innen

Amide proton transfer-weighted imagingLymph node metastasesNon-small cell lung cancerPositron emission tomographyRestrictive spectrum imaging

Substanzen

Fluorodeoxyglucose F18Radiopharmaceuticals

Autor:innen und Institutionen

  • Department of Radiology, Henan Provincial People's Hospital and Zhengzhou University People's Hospital, Zhengzhou, China.
  • Laboratory of Brain Science and Brain-Like Intelligence Technology, Institute for Integrated Medical Science and Engineering, Henan Academy of Sciences, Zhengzhou, China.
  • Biomedical Research Institute, Henan Academy of Sciences, Zhengzhou, China.
  • Department of Radiology, Xinxiang Medical University People's Hospital and Henan Provincial People's Hospital, Zhengzhou, China.
  • Central Research Institute, United Imaging Healthcare Group, Shanghai, China.
  • Beijing United Imaging Research Institute of Intelligent Imaging, United Imaging Healthcare Group, Beijing, China.

Förderung

  • The National Key R&D Program of China
  • the National Natural Science Foundation of China
  • the Zhongyuan Thousand Talents Plan Project - Basic Research Leader Talent
  • the Zhengzhou Collaborative Innovation Major Project
  • the Joint Fund of Henan Province Science and Technology R&D Program

Zitieren

APA

Meng, N., Liu, X., Zhou, Y., Yu, X., Wu, Y., Fu, F., Yuan, J., Yang, Y., Wang, Z., & Wang, M. (2025). Multiparametric 18F-FDG PET/MRI based on restrictive spectrum imaging and amide proton transfer-weighted imaging facilitates the assessment of lymph node metastases in non-small cell lung cancer. La radiologia medica. https://doi.org/10.1007/s11547-025-01992-2

Vancouver

Meng N, Liu X, Zhou Y, Yu X, Wu Y, Fu F, et al. Multiparametric 18F-FDG PET/MRI based on restrictive spectrum imaging and amide proton transfer-weighted imaging facilitates the assessment of lymph node metastases in non-small cell lung cancer. La radiologia medica. 2025. doi:10.1007/s11547-025-01992-2

BibTeX
@article{Meng2025,
  author = {Meng, Nan and Liu, Xue and Zhou, Yihang and Yu, Xuan and Wu, Yaping and Fu, Fangfang and Yuan, Jianmin and Yang, Yang and Wang, Zhe and Wang, Meiyun},
  title = {Multiparametric 18F-FDG PET/MRI based on restrictive spectrum imaging and amide proton transfer-weighted imaging facilitates the assessment of lymph node metastases in non-small cell lung cancer},
  journal = {La radiologia medica},
  year = {2025},
  doi = {10.1007/s11547-025-01992-2}
}
Kostenlos starten →